... @peppers1
I don't think everything needs to go right here. If everything goes right we are way over $3.50.
Kaken was selling to 16% of their market in year 1.
If everything goes right, and BOT sells to 15% of it's market in year 1.
570,000 patients ( 4 scripts each )
2.28 Million scripts at 750 USD each
1.7B USD gross sales
Approx $500M USD profit ( 750M AUD )
PE 15 $ 11B AUD MC.... about $8 per share.
If everything was going right though, the PE would be higher than 15, more like 30
$16 per share.
We need to gauge success on something, why not what Kaken achieved in year 1?
... @peppers1I don't think everything needs to go right here. If...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |